Overweight and obesity status causes nearly half a million new cancer cases each year
the ONA take:
According to a new study published in the journal The Lancet Oncology, researchers from the International Agency for Research on Cancer have found that nearly half a million new cases of cancer each year are a result of high body mass index (BMI).
For the study, researchers analyzed data from 2012 and found that 3.6% of all new cancer cases are associated with high BMI. In addition, they found that cancer linked with being overweight or obese is much more common in developed countries compared with less developed countries. North America had the highest rate of overweight and obesity-related cancer; of all BMI-related cancer cases across the globe, 23% occur in North America.
Results showed that Europe too has a large BMI-related cancer burden, particularly in Eastern Europe where 6.5% of all new cancer cases in Europe occurred there. China contributes 50,000 BMI-related cancer cases each year. On the other hand, Africa only had 1.5% of BMI-related new cancer cases in 2012.
Furthermore, women were found to more likely develop BMI-related cancer than men (5.3% of BMI-linked new cancer cases versus 1.9%). The most common BMI-related cancers in women were endometrium, colon, and breast, while kidney and colon were the most common BMI-linked cancer in men.
Nearly half a million new cases of cancer each year are a result of high BMI.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Clinical Use of Cabozantinib in the Treatment of Advanced Kidney Cancer: Efficacy, Safety, and Patient Selection
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|